In the new list of medicines included in basic medical insurance ("Yi Bao"), anti-virals (ARVs) are growing, among them: In addition to Fancyclovir, Gancyclovir, and “LinJiaSuanNa”, 11 types of ARV are also included in the list. This includes: Nucleoside Reverse Transcriptase Inhibitors (lamivudine, zidovudine, didanosine, stavudine, and abacavir), Non-Nucleoside Reverse Transcriptase Inhibitors (nevirapine, efavirenz), and Protease Inhibitors (indinavir, ritonavir, nelfinavir, and saquinavir). These 11 types of medicine are all limited to use for HIV-related conditions. There are also new drugs limited to the treatment of Acute Influenza, "Ausitawei" and to the treatment of active Hepatitis-B, Lamivudine.

The inclusion of anti-AIDS ARV medicines on the national medical insurance list is a sign of the importance placed on AIDS treatment by the nation, and represents a major help for people suffering from HIV/AIDS. It will also further open the market for ARV medicines.

Source: Health News Web

China AIDS Info is a non-commercial, non-profit website. All information and news is provided in the public interest and is strictly for personal, academic, or other non-commercial use.